In this article, we will discuss Anlotinib (Therapeutic Efficacy-1). So, let’s get started.
- Advanced NSCLC
- NSCLC is one of the most common diseases used to study the efficacy and safety of anlotinib. As no standard third-line treatment is available for patients with advanced NSCLC, anlotinib has mainly been investigated in this population to date.